Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data.
Dide den HollanderAnne R DirksonSuzan VerberneWessel KraaijGerard van OortmerssenHans GelderblomAstrid OostenAnna K L ReynersNeeltje SteeghsWinette T A van der GraafIngrid M E DesarOlga HussonPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
This first overview of patient-reported imatinib-related symptoms from two data sources helps to determine coverage of items in existing questionnaires, and prioritize HRQoL issues. Combining cancer-generic instruments with treatment-specific item lists will improve future HRQoL assessment in care and research in GIST patients using TKI.
Keyphrases
- patient reported
- end stage renal disease
- newly diagnosed
- ejection fraction
- healthcare
- prognostic factors
- patient reported outcomes
- palliative care
- electronic health record
- machine learning
- physical activity
- depressive symptoms
- psychometric properties
- tyrosine kinase
- papillary thyroid
- pain management
- current status
- chronic pain
- health insurance